Result of WRAP Retail Offer
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your VAL notes
ValiRx Plc (AIM: VAL), a life sciences company focusing on early-stage cancer therapeutics and women's health, is pleased to confirm, further to the announcements made on 30 October 2025, the result of WRAP Retail Offer at the Issue Price of 0.25 pence per share. The WRAP Retail Offer has raised gross proceeds of approximately £152,000, through the issue of 60,722,400 new ordinary shares of 0.1 pence each at a price of 0.25 pence per share (the "WRAP Retail Offer Shares"). With the gross proceeds of the Placing and Subscription of £750,000, in aggregate the Company has therefore raised gross proceeds of approximately £902,000 at a price of 0.25 pence per new Ordinary Share. In connection with the Fundraising the Company will grant 360,722,400 Fundraising Warrants and 16,036,120 Broker Warrants.
The issue of the Tranche 2 Placing Shares, Subscription Shares, WRAP Retail Offer Shares and the grant of the Fundraising Warrants and Broker Warrants are subject to the passing of the Fundraising Resolutions at the General Meeting.
Admission
Subject to, inter alia, the passing of the Fundraising Resolutions, application will be made to the London Stock Exchange for the Tranche 2 Placing Shares, Subscription Shares, Fee Shares and WRAP Retail Offer Shares to be admitted to trading on AIM. It is anticipated that Tranche 2 Admission will become effective and that dealings in the Tranche 2 Placing Shares, Subscription Shares, WRAP Retail Offer Shares will commence on AIM at 8.00 a.m. on or around 21 November 2025.
Terms used but not defined in this announcement have the same meaning as set out in the Company's announcement released at 7:17 a.m. on 30 October 2025.
| Investor questions on this announcement We encourage all investors to share questions on this announcement via our investor hub | https://valirx.com/link/P76jor |
| ValiRx plc Dr Mark Eccleston, CEO | Tel: +44 115 784 0026 www.valirx.com Mark.Eccleston@valirx.com |
| Cairn Financial Advisers LLP (Nominated Adviser) Liam Murray / Ludovico Lazzaretti | Tel: +44 (0) 20 7213 0880 |
| Shard Capital Partners LLP (Sole Broker) Damon Heath | Tel: +44 (0) 20 7186 9000 |
| V Formation (Public Relations) Lucy Wharton - Senior PR Executive Sue Carr - Director | +44 (0) 115 787 0206 www.vformation.biz lucy@vformation.biz sue@vformation.biz |
| Winterflood Retail Access Platform Sophia Bechev / Kaitlan Billings | WRAP@winterflood.com +44(0) 20 3100 0286 |
The Company's LEI is 213800VQKB9SJCQDET40.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.